03/28/2024
4:23 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
7:20 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/21/2024
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
2:47 PM | Altium Capital Management LP (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
02/07/2024
4:03 PM | ACORN BIOVENTURES, L.P. (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
01/31/2024
3:56 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
SCHWARTZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
8:15 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/19/2024
3:58 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/12/2024
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
12:35 PM | Altium Capital Management LP (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G | |
01/04/2024
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
8:28 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
12/26/2023
8:29 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
8:20 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
11/28/2023
8:31 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/13/2023
11:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
09/01/2023
4:12 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/24/2023
3:02 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/07/2023
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
3:55 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
HENNEY CHRISTOPHER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:56 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Ferguson Kenneth M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:56 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Walker Karin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:56 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Kirschbaum Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:57 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
McBarron Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:57 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Spiegel Robert J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:57 PM | BARKER SAM L (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:58 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Rombotis Spiro George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
4:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
3:06 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
4:22 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
04/28/2023
4:24 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
04/28/2023
4:30 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form ARS | |
